scienc
alway
seiz
attent
toward
unusu
thing
harvest
act
potent
cure
human
disord
poison
venom
produc
organ
caus
mortal
sourc
medicin
human
syndrom
sinc
time
immemori
histori
say
ancient
rome
anim
venom
often
use
diagnos
smallpox
fever
leprosi
wound
heal
utkin
one
best
contribut
anim
venom
medic
scienc
discoveri
bradykinin
rocha
e
silva
team
rocha
e
silva
et
al
reduc
contract
isol
guinea
pig
ileum
upon
incub
globulin
fraction
dog
plasma
snake
venom
obtain
bothrop
jararaca
arthropod
envenom
usual
common
summer
month
year
due
increas
agricultur
activ
bawaskar
bawaskar
secret
venom
respons
extern
stimuli
captur
prey
surviv
predat
henc
build
dynasti
planet
optimum
concentr
venom
find
applic
field
biotechnolog
prevent
cure
pharmacolog
disord
exert
effect
interact
rang
target
includ
cellular
receptor
membran
ion
channel
venom
compon
elapid
snake
bungaru
multicinctu
type
prove
fatal
bind
irrevers
nicotin
acetylcholin
receptor
one
best
exampl
applic
toxin
medic
research
utkin
young
et
al
tumour
paint
outlin
natur
toxin
peptid
natur
organ
viz
scorpion
fluoresc
molecul
bunch
scientist
blaze
bioscienc
fred
hutchinson
cancer
research
centr
univers
washington
interpret
whereabout
cancer
bodi
plummer
drug
resist
advers
drug
reaction
patient
arous
find
altern
better
live
condit
human
investig
gener
deriv
activ
compon
anim
venom
ongo
implement
erad
cure
human
disord
one
exampl
obtain
substitut
posit
charg
amino
acid
scorpion
venom
peptid
desarrollo
climat
condit
origin
place
essenti
factor
influenc
concentr
qualiti
toxin
present
arthropod
utkin
alter
live
condit
venom
extract
procedur
tailor
venom
toxic
composit
utkin
emerg
method
proteom
genom
evok
find
newer
compound
aid
formul
altern
pharmaceut
utkin
review
elabor
rather
prais
novelti
scorpion
venom
applic
pharmaceut
scienc
breakthrough
research
develop
scienc
technolog
novel
approach
adopt
unveil
venom
toxin
bind
antivenom
amalgam
form
venom
immun
mixtur
william
et
al
casewel
et
al
discoveri
captopril
venom
brazilian
snake
bothrop
jararaca
utkin
escouba
king
ace
inhibitor
use
treatment
hypertens
remark
discoveri
earliest
success
use
concept
ligandbas
drug
design
utkin
research
proven
venom
arachnid
decreas
risk
heart
transplant
utkin
block
ntype
calcium
channel
analges
activ
mediat
venom
peptid
snail
conu
magu
escouba
king
scorpion
class
arachnida
order
scorpion
predatori
arachnid
occupi
terrestri
habitat
except
antarctica
buthida
famili
characterist
triangularshap
sternum
wide
studi
danger
scorpion
among
et
al
earlier
day
twentieth
centuri
scorpion
oil
mani
applic
tumor
infect
inflammatori
condit
podnar
incid
scorpion
envenom
reduc
asia
though
establish
report
hint
southern
india
affect
zone
bawaskar
bawaskar
venom
amalgam
peptid
protein
nucleotid
amin
fig
emerg
cur
mani
disord
includ
cancer
fig
often
lack
enzym
venom
except
mesobuthu
tamulu
centruroid
exilicauda
scorpion
belong
heterometru
sp
gwee
et
al
autonom
nervou
system
perturb
scorpion
envenom
elev
insulin
releas
glucagon
cortisol
angiotensin
ii
krishnamurthi
scorpion
venom
toxin
svt
exert
pharmacolog
activ
human
ion
channel
na
k
kastin
block
potassium
chlorid
channel
short
chain
peptid
act
upon
sodium
calcium
channel
long
chain
peptid
smith
et
al
petricevich
possani
et
al
sodium
channel
act
toxin
shown
effect
mammal
includ
human
ortiz
et
al
venom
contain
structur
divers
peptid
disulphid
bridg
exhibit
multipl
pharmacolog
properti
stabl
ortiz
et
al
peptid
mixtur
known
trigger
cell
death
ortiz
et
al
form
pore
biolog
membran
novel
concept
destroy
unwant
cell
initi
apoptosi
scorpion
toxin
classifi
accord
ion
channel
exhibit
pharmacolog
activ
b
threedimension
structur
c
respect
receptor
bind
action
deliv
upon
receptor
gome
et
al
petricevich
et
al
genu
speci
scorpion
age
physiolog
feed
state
region
inhabit
factor
govern
venom
toxic
oukkach
et
al
adopt
fruit
extract
procedur
collect
highqual
venom
crucial
oukkach
et
al
stimul
abdomen
yield
less
toxic
transpar
venom
rather
prevenom
combin
salt
peptid
elicit
pain
extern
stimul
appli
electr
shock
scorpion
gener
highli
concentr
toxin
gome
et
al
oukkach
et
al
inceoglu
et
al
prevenom
differ
venom
vari
physic
chemic
characterist
greater
concentr
k
salt
modul
excit
k
channel
target
organ
oukkach
et
al
inceoglu
et
al
ph
freshli
collect
venom
rang
neutral
alkalin
oukkach
et
al
team
research
ben
sik
hassan
ii
univers
morocco
design
portabl
robot
milk
scorpion
lessen
risk
venom
gland
punctur
plummer
mucroporin
scorpin
hadrurin
etc
antimicrobi
peptid
amp
obtain
scorpion
ortiz
et
al
broadspectrum
activ
viral
pathogen
name
rotaviru
measl
viru
adenoviru
etc
ortiz
et
al
petricevich
et
al
mucroporin
deriv
venom
scorpion
lycha
mucronatu
proven
possess
antimicrobi
activ
bacteria
measl
viru
ortiz
et
al
petricevich
et
al
hadrurin
scorpion
hadruru
aztecu
heinen
da
veiga
inhibit
growth
gram
posit
gram
neg
bacteria
petricevich
et
al
zeng
et
al
antibiot
amoxicillin
cefuroxim
erythromycin
combin
parabutoporin
scorpion
parabuthu
schlechteri
deriv
african
yellow
leg
scorpion
opistophthalmu
carinatu
display
synergist
antibacteri
activ
zeng
et
al
parabutoporin
antibiot
peptid
obtain
scorpion
signific
immunoregulatori
effect
remijsen
et
al
willem
et
al
anoth
ndbp
identifi
buthu
martensii
karsch
establish
satisfactori
antimicrobi
candid
gram
neg
posit
bacteria
zeng
et
al
stigmurin
two
ndbp
scorpion
tityu
stigmuru
exhibit
bactericid
bacteriostat
activ
studi
conduct
danielesilva
et
al
potent
control
sepsi
lung
caecum
anim
danielesilva
et
al
hp
first
report
antivir
peptid
collect
venom
gland
scorpion
heterometru
petersii
hp
hp
structur
homolog
function
distinct
former
success
candid
inhibit
invitro
hepat
c
viru
hcv
viru
resist
antivir
agent
infect
ortiz
et
al
gome
da
mata
et
al
yan
et
al
venom
peptid
exert
activ
either
disrupt
viral
coat
preoccupi
receptor
prevent
viral
entri
cell
gome
da
mata
et
al
antimicrobi
peptid
design
amplifi
structur
net
posit
charg
replac
glycin
alanin
serin
lysin
ariginin
chen
et
al
hemolyt
valu
substanti
decreas
ortiz
et
al
peptid
directli
target
particl
thu
ceas
viral
activ
assumpt
made
chen
et
al
mode
action
indic
peptid
enter
viral
coat
dismantl
two
segment
hydrophil
hydrophob
hydrophil
partform
innermost
region
along
posit
charg
peptid
chen
et
al
also
signific
inhibitori
role
replicationcompet
viru
gwee
et
al
chen
et
al
hmed
et
al
substanti
inhibitori
activ
antihiv
assay
done
adopt
replicationcompet
viru
peptid
interact
viral
particl
strongli
inhibit
replicationcompet
viru
et
al
compound
also
resist
growth
gram
neg
gram
posit
bacteria
bacteri
strain
becom
resist
antibiot
ortiz
et
al
anoth
peptid
mucroporin
reveal
potent
antihiv
activ
prevent
chemokin
receptor
activ
hmed
et
al
even
success
appli
topic
aureu
infect
ortiz
et
al
substanti
antivir
agent
show
activ
measl
viru
sar
coronaviru
influenza
viru
subtyp
inhibit
amplif
hepatitisb
viru
ortiz
et
al
gome
da
mata
et
al
ndbp
scorpion
chaerilu
tryznai
initi
inactiv
viral
particl
hcv
cell
owe
low
bioavail
unsuccess
inhibit
establish
infect
led
design
effect
histidinerich
peptid
use
sourc
peptid
templat
peptid
prove
effici
hcv
infect
gome
da
mata
et
al
crude
venom
egyptian
scorpion
scorpiomauru
palmatu
androctonu
australi
deliv
antivir
activ
hcv
vitro
cell
cultur
experi
carri
elbitar
et
al
gome
da
mata
et
al
elbitar
et
al
conclud
antivir
activ
scorpiomauru
palmatu
remain
consist
posttreat
heat
elbitar
et
al
pave
way
futur
antivir
therapeut
recent
discoveri
indic
two
venom
peptid
hp
hp
h
petersii
destruct
activ
herp
simplex
viru
ortiz
et
al
venom
compon
italian
scorpion
hemiscorpiu
lepturu
prove
activ
hiv
infect
valu
zabihollahi
et
al
scorpion
neurotoxin
bind
effect
long
time
threedimension
backbon
highli
stabl
presenc
three
four
db
hmed
et
al
compound
present
scorpion
venom
mostli
target
nervou
system
podnar
buthu
martensii
karsch
bmk
famili
buthida
scorpion
chines
scorpion
wide
use
ethnomedicin
china
treatment
neurolog
diseas
includ
cerebr
palsi
epilepsi
apoplexi
hmed
et
al
antinocicept
effect
observ
bmk
obtain
buthu
martensii
karsch
sensori
nerv
hmed
et
al
scorpion
deriv
toxin
exhibit
antinocicept
activ
includ
amm
viii
hmed
et
al
envenom
associ
death
individu
due
cardiovascular
toxic
caus
catecholamin
releas
initi
pulmonari
oedema
final
cardiac
arrest
gwee
et
al
venom
scorpion
leiuru
quinquestriatu
develop
synergist
effect
along
alkaloid
neurotoxin
like
veratridin
batrachotoxin
aconitin
regul
action
potenti
heinen
da
veiga
catteral
revers
heterotroph
cooper
site
action
neurotoxin
venom
toxin
catteral
reorient
properti
na
ionophor
noncoval
interact
heinen
da
veiga
catteral
present
research
univers
collima
ucol
investig
anim
model
scorpion
venom
toxin
effect
releas
dopamin
attach
receptor
dopaminerg
neuron
desarrollo
releas
dopamin
cure
parkinson
diseas
desarrollo
lorenzo
et
al
condit
dopamin
releas
inhibit
muscl
movement
prevent
antimalari
activ
exhibit
peptid
cytolyt
k
channel
block
activ
n
cterminu
respect
et
al
scorpin
dbp
first
describ
antimalari
peptid
isol
venom
emperor
scorpion
pandinu
imper
famili
scorpionida
ortiz
et
al
peptid
mm
concentr
respect
display
death
sexual
stage
plasmodium
berghei
deplet
plasmodium
falciparum
parasit
et
al
amp
reveal
cytolyt
activ
bacteria
fungi
yeast
obtain
genet
sequenc
venom
gland
intens
activ
inhibit
malari
parasit
without
impair
normal
function
mammalian
cell
gao
et
al
pandinin
ctriporin
ndbp
inhibitori
role
growth
fungu
candida
albican
respons
candidiasi
infect
human
yeast
saccharomyc
cerevisia
inhibit
parabutoporin
opistoporin
ortiz
et
al
bradykinin
potenti
scorpion
venom
peptid
devoid
disulphid
bridg
enrich
prolin
residu
cterminu
goudarzi
et
al
studi
report
prolin
enrich
ctermin
end
contribut
increas
bradykinin
potenti
activ
goudarzi
et
al
uniqu
characterist
peptid
function
involv
synergist
action
bradykinin
proteolysi
prevent
rioli
et
al
thirst
excav
bradykinin
potenti
arthropod
venom
peptid
activ
argininosuccin
synthetas
ongo
act
potenti
target
reduc
arteri
blood
pressur
camargo
et
al
venom
extract
scorpion
serrulatu
b
occitanu
contain
bradykininpotenti
peptid
peptid
respect
petricevich
et
al
zeng
et
al
peptid
first
discov
ndbp
capabl
initi
invivo
bradykinin
activ
petricevich
et
al
zeng
et
al
peptid
notabl
strong
hypotens
agent
petricevich
et
al
studi
serrulatu
reveal
bradykinin
potenti
activ
regul
blood
pressur
bradykinin
receptor
synthesi
ace
activ
avert
goudarzi
et
al
first
member
serrulatu
hypotens
famili
achiev
success
initi
hypotens
effect
bradykinin
normal
rat
veranobraga
et
al
synthet
analog
design
use
ctermin
peptid
nativ
member
compound
show
bradykinin
independ
hypotens
activ
veranobraga
et
al
bmkbpp
bradykinin
potenti
peptid
identifi
cdna
clone
scorpion
b
martensii
karsch
zeng
et
al
goudarzi
et
al
conduct
studi
illustr
bradykinin
potenti
activ
three
iranian
scorpion
name
hottentotta
saulcyi
odontobuthu
doria
mesobuthu
eupeu
demonstr
effect
use
organ
bath
instrument
guinea
pig
ileum
rat
uteru
tissu
goudarzi
et
al
natur
therapi
plant
anim
deriv
occupi
vast
section
gradual
antineoplast
cytotox
agent
due
increas
uncontrol
advers
effect
ineffect
possibl
metastasi
recurr
condit
chemotherapi
radiotherapi
last
three
decad
seen
attempt
detect
promis
anticanc
activ
anim
venom
toxin
present
clinic
trial
lorenzo
et
al
scorpion
venom
amaz
therapeut
agent
cancer
inflict
upon
cancer
cell
arrest
cell
cycl
sphase
therebi
act
prolif
curb
lorenzo
et
al
ahluwalia
shah
svt
induc
apoptosi
aggrav
neoplast
cell
amplifi
product
nitric
oxid
show
activ
depolar
mitochondri
membran
ahluwalia
shah
present
posit
result
invivo
invitro
examin
phase
ii
clinic
trial
proven
svt
anticanc
therapeut
agent
kastin
cuba
dominican
republ
island
dwell
blue
red
scorpion
rhopaluru
junceu
steadili
gain
fame
antineoplast
podnar
lorenzo
et
al
thrust
area
inquisit
research
numer
experi
execut
arthropod
evalu
pharmacolog
aspect
protein
constitu
scorpion
abolish
cancer
cell
prolifer
ahluwalia
shah
nativ
caribbean
island
use
venom
antitumor
agent
sinc
podnar
novel
discoveri
elucid
venom
scorpion
act
pain
reliev
replenish
energi
cancer
patient
lorenzo
et
al
recent
research
work
propos
et
al
treatment
recalcitr
tripl
neg
breast
cancer
tnbc
cell
line
demonstr
high
cytotox
activ
arthropod
venom
break
ground
new
therapeut
approach
et
al
tradit
use
venom
bmk
scorpion
possessor
multipl
pharmacolog
activ
includ
cancer
brain
tumor
found
effect
brain
tumor
cell
line
gome
et
al
et
al
antitumoranalges
peptid
agap
obtain
applic
recombin
dna
technolog
scorpion
venom
express
escherichia
coli
confirm
analges
antitumor
activ
mice
hmed
et
al
peptid
much
lower
dose
compar
antineoplast
agent
reveal
increas
antitumor
activ
advers
effect
oukkach
et
al
inhibit
glioma
cell
prolifer
regul
ion
channel
gome
et
al
peptid
isol
scorpion
proven
antithrombot
petricevich
et
al
anoth
polypeptid
dosedepend
inhibitori
activ
arrest
cell
cycl
prostat
cancer
cell
line
phase
mishal
et
al
zhang
et
al
antiapoptot
role
polypeptid
due
highli
express
bax
proapoptot
downregul
antiapoptot
zhang
et
al
enzym
procur
extract
purif
scorpion
hamper
overexpress
surfac
marker
cancer
cell
hmed
et
al
indian
black
scorpion
heterometru
bengalensi
koch
venom
show
cell
growth
inhibit
cell
cycl
arrest
apoptogen
featur
antiprolif
role
explor
human
leukem
cell
da
gupta
et
al
peptid
neopladin
neopladin
venom
obtain
scorpion
tityu
discrepan
test
cell
human
breast
cancer
cell
bind
induc
apoptosi
fasl
express
effect
found
proport
time
ahluwalia
shah
suze
et
al
ning
et
al
conduct
vivo
studi
success
implant
lewi
lung
cell
onto
subcutan
layer
mice
explor
apoptot
effect
scorpion
venom
deriv
polypeptid
tumor
cell
ahluwalia
shah
ning
et
al
target
hint
polypeptid
compar
cyclophosphamid
alkyl
agent
show
improv
apoptot
activ
inhibit
vegf
express
assist
matur
dendrit
cell
ahluwalia
shah
ning
et
al
chlorotoxin
small
protein
contain
amino
acid
result
paralysi
normal
cell
scorpion
defend
aggressor
captur
prey
dardevet
et
al
toxin
ceas
metastasi
invas
check
mobil
cancer
cell
chen
et
al
inabl
chlorotoxin
bind
normal
human
cell
suggest
nontox
effect
podnar
gome
et
al
invitro
condit
peptid
shown
impair
glioma
invas
inhibit
gelatinas
activ
gome
et
al
matrix
metalloproteinas
chlorotoxin
mix
type
igg
antibodi
obtain
requir
structur
capabl
target
tumor
cell
bancroft
sun
et
al
select
chlorotoxin
measur
screen
earli
detect
cancer
skin
esophagu
colon
lung
gome
et
al
toxin
found
compet
quicker
identif
posit
lymph
node
breast
prostat
testicular
cancer
henc
prognosi
done
faster
heinen
da
veiga
scorpion
venom
compon
iii
svc
iii
profound
activ
signal
pathway
role
immunocyt
gener
lymphocyt
develop
cell
apoptosi
thu
select
act
upon
human
leukemia
jurkat
cell
line
cell
mishal
et
al
svc
iii
prevent
cyclin
product
inhibit
cell
cycl
phase
mishal
et
al
venom
deriv
odontobuthu
doria
capabl
platelet
aggreg
possess
proteolyt
enzym
mishal
et
al
cytotox
apoptogen
agent
lactas
dehydrogenas
ldh
mishal
et
al
ldh
lower
cell
viabil
activ
mitochondri
depolar
ahluwalia
shah
proteas
deriv
scorpion
mesobuthu
gibbosu
proteolyt
gelatinolyt
human
lung
adenocarcinoma
cell
line
mishal
et
al
extens
research
venom
blue
scorpion
drawn
conclus
analges
antiinflammatori
antitumor
agent
podnar
support
research
drug
name
vidatox
formul
labiofam
cuban
compani
report
lessen
spread
cancer
cell
increas
life
expect
among
cancer
patient
neglig
side
effect
patient
podnar
scorpion
venom
induc
apoptosi
hela
cell
line
via
extrins
intrins
pathway
upregul
stimul
bax
downregul
et
al
cell
necrosi
demonstr
et
al
notic
along
bax
downregul
scorpion
venom
examin
et
al
demetrio
rodriguez
fajardo
mexican
gain
enough
recognit
discov
low
molecular
weight
protein
scorpion
venom
develop
prodrug
use
treatment
breast
cancer
takahashi
even
quot
protein
profound
inhibitori
activ
uterin
cancer
cell
protein
drug
substanc
treatment
cancer
efficaci
convent
therapi
even
diabet
patient
takahashi
zargan
et
al
conduct
studi
human
breast
cancer
cell
line
put
practic
venom
odontobuthu
doria
famili
buthida
yellow
iranian
scorpion
zargan
et
al
confirm
venom
suppressor
dna
synthesi
arrest
sphase
zargan
et
al
furthermor
induc
apoptosi
increas
reactiv
nitrogen
intermedi
depolar
mitochondri
membran
activ
ahluwalia
shah
zargan
et
al
reduct
tumor
size
antiprolif
activ
observ
studi
conduct
mice
venom
peptid
also
potassium
channel
blocker
extract
centruroid
margaritatu
chaisakul
et
al
pan
fellow
cowork
univers
illinoi
initi
invitro
target
cancer
cell
construct
nanoparticl
encapsul
name
nano
venin
svt
peptid
liu
et
al
research
team
ucol
though
primari
stage
research
say
venom
toxin
contain
peptid
bind
ion
channel
cancer
cell
induc
death
desarrollo
gome
et
al
scorpion
ageold
arthropod
possess
venom
first
util
field
medicin
antivenom
rather
antibodi
scorpion
sting
petricevich
et
al
highli
toxic
venom
elev
valu
consid
effect
formul
antivenom
oukkach
et
al
investig
eject
fluid
turn
fruit
manifold
applic
medicin
doctor
prefer
use
venom
anaesthet
paralyz
bodi
perform
longterm
surgeri
podnar
venom
uroplect
lineatu
find
clinic
applic
field
dermatolog
rapini
et
al
possessor
hyaluronidas
scorpion
venom
inhibit
hyaluronan
import
metastasi
caus
capac
present
breast
cancer
cell
line
mishal
et
al
increas
calcium
ion
influx
rather
immunomodulatori
role
ndbp
anoth
notabl
activ
svt
danielesilva
et
al
exampl
includ
peptid
parabutoporin
opistoporin
indulg
modifi
product
superoxid
chemotaxi
concentr
danielesilva
et
al
cysteinefre
peptid
venom
scorpion
pandinu
inhibit
growth
pathogen
vancomycinresist
enterococcu
vre
caus
organ
mani
human
infect
thu
gain
notic
treatment
vre
infect
zeng
et
al
toxin
shortchain
act
potassium
voltageg
channel
blocker
therebi
reduc
tlymphocyt
tcell
prolifer
principl
appli
treatment
autoimmun
disord
like
rheumatoid
arthriti
chandi
et
al
toxin
sourc
peptidyl
inhibitor
potassium
channel
possess
antiinflammatori
antiprolif
role
depolar
human
cell
petricevich
et
al
increment
newer
techniqu
field
research
develop
r
led
scientist
brood
find
cure
natur
plant
anim
rough
estim
bring
forth
fact
encompass
constant
usag
nearli
natur
formul
pharmaceut
burk
evolut
proteom
genom
transcriptom
drug
discoveri
natur
resourc
splendid
approach
though
hand
biolog
import
toxin
could
deriv
toxinsecret
anim
still
call
revolut
fetch
cure
anim
thu
mandatori
gain
thorough
knowledg
evolutionari
histori
ecolog
anim
put
practic
develop
futur
pharmaceut
casewel
et
al
process
establish
chemic
entiti
clinic
candid
enorm
timeconsum
process
thousand
potenti
candid
screen
potenti
emerg
face
challeng
pharmaceut
market
till
date
venom
peptid
deriv
drug
approv
fda
furthermor
undergo
clinic
trial
stage
preclin
develop
henney
captopril
ziconotid
atracurium
eptifibatid
establish
drug
product
formul
venom
toxin
harvey
synergist
properti
exhibit
k
salt
peptid
scorpion
prevenom
venom
constitu
indic
discoveri
effect
pharmaceut
near
futur
inceoglu
et
al
drug
pharmaceut
tend
affin
toward
ion
channel
bodi
conserv
human
physiolog
usual
therapeut
advanc
made
target
channel
bennett
guthri
kaczorowski
et
al
venom
peptid
reservoir
chemic
compon
tool
identifi
character
function
structur
ion
channel
bodi
rational
underli
choic
target
ion
channel
lie
increas
access
success
deliv
intend
pharmacolog
activ
upon
target
tradit
novel
drug
kaczorowski
et
al
niemey
et
al
failur
drug
candid
new
drug
applic
nda
often
lie
interact
unrel
target
channel
kaczorowski
et
al
key
ion
channel
drug
discoveri
embed
approach
includ
invivo
vitro
target
candid
drug
product
tradit
drug
ziconotid
one
exampl
develop
treat
pain
induc
intrathec
administr
vivo
method
henc
confirm
treat
pain
calcium
channel
blocker
kaczorowski
et
al
voltageg
sodium
channel
enorm
contribut
bloom
metastasi
mani
cancer
enrich
channel
hmed
et
al
said
potassium
channel
ardent
activ
promot
prolifer
tumour
cell
villalonga
et
al
svt
bona
fide
blocker
k
channel
highli
efficaci
activ
pharmaceut
agent
petricevich
et
al
cremonez
et
al
channel
seldom
act
therapeut
target
diagnosi
cardiovascular
diseas
autoimmun
disord
inflamm
bergeron
bingham
report
confirm
signal
channel
express
often
associ
cancer
prolifer
metastasi
monteith
et
al
innumer
channel
mark
heart
diseas
migrain
niemey
et
al
venom
anim
enrich
divers
venom
compon
profici
target
voltageg
ion
channel
favour
analysi
channel
isoform
israel
et
al
noxiustoxin
first
k
channel
blocker
isol
scorpion
centruroid
noxiu
date
back
year
dutertr
lewi
svt
compon
modifi
sodium
channel
first
identifi
neurotoxin
abolish
specif
channel
activ
zhu
gao
sodium
potassium
channel
aim
svt
compos
roughli
amino
acid
disulphid
bridg
amino
acid
respect
petricevich
et
al
longchain
svt
exert
effect
vertebr
voltageg
sodium
channel
gwee
et
al
petricevich
et
al
two
petricevich
et
al
fig
bind
receptor
site
linger
inactiv
channel
gwee
et
al
receptor
boost
activ
channel
gwee
et
al
k
channel
toxin
accordingli
classifi
potassium
toxin
basi
cystein
pair
sequenc
ident
dutertr
lewi
k
channel
svt
bind
revers
exterior
portion
channel
hinder
passag
ion
membran
gwee
et
al
petricevich
et
al
sole
select
inhibitor
k
channel
iberiotoxin
obtain
scorpion
b
tamulu
gwee
et
al
peptid
compon
venom
collect
scorpion
buthotu
hottenta
first
exert
activ
ryanodin
receptor
receptor
releas
store
calcium
endoplasm
sarcoplasm
reticulum
et
al
ryanotoxin
anoth
peptid
induc
receptor
subconduct
state
purifi
scorpion
buthotu
judaicu
et
al
venom
peptid
pandinu
imper
high
affin
ryanodin
receptor
et
al
research
persist
ponder
reshap
drug
candid
act
ligand
receptor
new
therapeut
approach
thu
achiev
burk
venom
toxin
therapeut
approach
modifi
make
amend
outer
coat
orient
releas
kinet
act
prodrug
time
administr
upon
contact
substrat
exhibit
activ
zargan
et
al
inspit
potent
bradykinin
potenti
examin
found
exert
antiinflammatori
proangiogen
antifibrogen
activ
therebi
propos
drug
candid
chronic
diseas
cassinivieira
et
al
subsequ
approach
drug
deliveri
clinic
benefici
healthi
normal
cell
loos
commun
toxin
prolifer
less
hamper
victim
get
reliev
diseas
divers
natur
medicin
properti
serv
healer
man
embrac
potenti
sinc
evolut
arthropod
secret
venom
order
protect
predat
venom
upon
contact
man
deliv
chang
physiolog
activ
har
therapi
thu
arthropod
venom
occupi
nich
pharmaceut
industri
applic
recombin
dna
technolog
especi
use
e
coli
system
due
simplic
high
effect
synthesi
peptid
becom
popular
everi
pass
day
zhang
et
al
amp
deriv
scorpion
venom
cytotox
eukaryot
cell
ortiz
et
al
minimum
inhibitori
concentr
mic
scorpion
ndbp
microorgan
concentr
cytotox
human
cell
close
ortiz
et
al
still
amp
find
applic
topic
appli
skin
infect
inhibit
growth
oral
bacteria
associ
plaqu
format
ortiz
et
al
zeng
et
al
obtain
clone
cdna
p
imper
bmkbpp
scorpion
mesobuthu
martensii
karsch
synthes
cdna
librari
vaejovi
mexicanu
smithi
amp
inhibit
growth
gram
neg
posit
bacteria
mic
prefer
non
toxic
human
erythrocyt
ortiz
et
al
confirm
antimicrobi
pharmaceut
industri
peptid
deriv
scorpion
venom
applic
biotechnolog
shown
amaz
result
pharmaceut
synthet
deriv
drug
product
fail
gener
task
static
cidal
toward
pathogen
peptid
come
action
exampl
includ
imcorporin
scorpion
isometru
maculatu
ctriporin
scorpion
chaerilu
tricostatu
vejovin
v
mexicanu
smithi
ortiz
et
al
antibiot
combin
amp
show
synergist
inhibitori
activ
toward
resist
strain
microb
ortiz
et
al
alarm
rise
pharmaceut
formul
cure
epidem
endem
pandem
diseas
evok
hope
svt
possessor
multipotenti
compon
sure
becom
heir
near
futur
molecul
draw
attent
preciou
tool
research
develop
newer
pharmaceut
formul
zargan
et
al
svt
outstand
perform
phase
phase
ii
clinic
trial
effect
therapeut
agent
huge
success
heinen
da
veiga
research
accomplish
benefit
scorpion
venom
ongo
corner
world
sure
hit
benchmark
next
decad
establish
better
world
